Signosis

Founded in 2007, Signosis provides molecular biology research tools and bioassay solutions for academic, biotech, and pharmaceutical research laboratories. With a focus on biomarker discovery, cell signalling pathways, transcription factor activity, cytokine analysis, and gene expression research and a portfolio of ELISA kits, transcription factor assays, reporter and stable cell lines, and biomarker detection platforms, Signosis is committed to empowering reserach innovation through improving the speed, sensitivity, and cost-effectiveness of biomedical research and accelerating drug discovery and translational science.

Cambridge Bioscience is pleased to provide Signosis products in the UK and Ireland.